NO993396D0
(no )
1999-07-09
Kinolin- ig kinolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi
DE60023982D1
(de )
2005-12-22
System zur Behandlung von benigner Prostatahyperplasie
NO20014560L
(no )
2001-09-19
Quinasoliner og terapautisk anvendelse derav
ATE355079T1
(de )
2006-03-15
Behandlung von prostata-krebs mit anti-erbb2 antikörpern
TR199801195T2
(xx )
1998-10-21
Tedavide yararl� kinolin ve kinozilin bile�ikleri.
TR200103216T2
(tr )
2002-04-22
Pirimidinon bileşimleri
EA200000220A1
(ru )
2000-10-30
Сочетание ингибитора тирозинкиназы и химической стерилизации для лечения рака предстательной железы
AU3011299A
(en )
1999-10-18
Combination therapy for the treatment of benign prostatic hyperplasia
DK0925069T3
(da )
2007-10-29
Anvendelse af Cetrorelix til behandling af godartet prostatahypertrofi og prostatacancer
DE60009888T2
(de )
2005-04-21
Substituierte 3-cyano-[1.7], [1.5] und [1.8]naphthyridininhibitoren von tyrosin kinasen
NO20020358L
(no )
2002-03-21
Anvendelse av etodolac til behandling av kreft
ATE361075T1
(de )
2007-05-15
Pharmazeutische kombination zur behandlung von benigner prostatahyperplasie oder zur langzeitvorbeugung von akuter harnzurückhaltung
PT984777E
(pt )
2004-01-30
Piperazinas arilsubstituidas uteis no tratamento da hiperplasia benigna da prostata
ZA991315B
(en )
2000-11-20
Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia.
BG106599A
(en )
2002-12-29
Wood treatment
NO20005548L
(no )
2000-12-04
Mykobakterieinhibitorer
ZA991319B
(en )
2000-11-20
Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia.
GT199700003A
(es )
1998-07-10
Compuestos de quinolina y quinazolina utiles en terapia.
BR9608912A
(pt )
1999-03-02
Agonistas de meletonina para o tratamento de hiperplasia prostática benigna
DE69807166D1
(de )
2002-09-19
Prostata-spezifische Antigen Inhibitore
GB9810895D0
(en )
1998-07-22
Combination therapy for the treatment of benign prostatic hyperplasia
HK1083070A
(en )
2006-06-23
Treatment of benign prostatic hyperplasia using energolytic agents
ES2181160T3
(es )
2003-02-16
Derivados de 1,4-dihidropiridina y su utilizacion en terapia.